Sympathomimetic amines should be used with considerable caution in patients with hypertension, hyperthyroidism, diabetes, heart disease, peripheral vascular disease, glaucoma and prostatic hypertrophy -- as well as those receiving MAO inhibitors. Patients aged 60 and older are more likely to experience adverse reactions to sympathomimetics. Overdosage of sympathomimetics in this age group may cause hallucinations, convulsions, CNS depression, and death. Hyperreactive individuals may display ephedrine-like reactions such as tachycardia, palpitations, headache, dizziness or nausea. Sympathomimetics have been associated with certain untoward reactions including fear, anxiety, nervousness, restlessness, tremor, weakness, pallor, respiratory difficulty, dysuria, insomnia, hallucinations, convulsions, CNS depression, arrhythmias, and cardiovascular collapse with hypotension.
Please see full Prescribing Information for complete details regarding warnings and precautions.
|
